Search by Drug Name or NDC

    NDC 42858-0225-01 DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1 Details

    DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1

    DEXMETHYLPHENIDATE HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rhodes Pharmaceuticals L.P.. The primary component is DEXMETHYLPHENIDATE HYDROCHLORIDE.

    Product Information

    NDC 42858-0225
    Product ID 42858-225_5c3a829d-205d-4ec7-b87b-ebe4dc754ac8
    Associated GPIs 61400016100330
    GCN Sequence Number 048983
    GCN Sequence Number Description dexmethylphenidate HCl TABLET 5 MG ORAL
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 14974
    HICL Sequence Number 022987
    HICL Sequence Number Description DEXMETHYLPHENIDATE HCL
    Brand/Generic Generic
    Proprietary Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Labeler Name Rhodes Pharmaceuticals L.P.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA208756
    Listing Certified Through n/a

    Package

    NDC 42858-0225-01 (42858022501)

    NDC Package Code 42858-225-01
    Billing NDC 42858022501
    Package 100 TABLET in 1 BOTTLE (42858-225-01)
    Marketing Start Date 2017-12-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.23644
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DEXMETHYLPHENIDATE 5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis